ABSTRACT. In this study, we attempted to establish a simple detection method for classification of IBV S1 genotypes by direct reverse transcriptase-polymerase chain reaction (RT-PCR). Then, to evaluate the usefulness of the S1 genotype-specific RT-PCR, we examined the relationship between S1 genotypes and serotypes of IBV in Japan. Sequencing of the S1 genes of IBV and phylogenetic tree analysis were conducted. On the basis of the sequencing data of the S1 genotype samples, we determined primer sets specific for each genotype. Five vaccine strains in Japan as reference strains and 46 field isolates were classified into different genetic clusters by phylogenetic tree analysis (JP-1, JP-II, JP-III, Mass and 4/91) and were matched to the results of S1 genotype-specific RT-PCR. A cross virus-neutralizing test showed that the five vaccine strains in Japan exhibited different serotypes from each other. The concordance rate of the 46 field isolates between the S1 genotypes and serotypes was 65.2%. The present study indicates that genotype-specific RT-PCR could be a convenient and useful tool for determining IBV serotypes and could contribute to the control of IBV outbreaks in Japan.
Infectious bronchitis is a highly contagious disease of chickens caused by infectious bronchitis virus (IBV), a member of Coronaviridae. Chickens infected with IBV develop respiratory disease, nephritis and reproductive disorders resulting in reduced egg production and quality. There are many serotypes of IB vaccines, and field IBV strains are continuously changing their antigenicity [2, 4] . In general, it is difficult to completely control IBV because the genetic changes of the virus occur far too frequently to develop and provide vaccines of the corresponding serotype [19] .
IBV belongs to Group 3 of the genus Coronavirus. Its genome consists of a 27.6 kb single-stranded positive-sense RNA and encodes three major structural proteins: nucleocapsid protein (N), surface spike glycoprotein (S) and membrane glycoprotein (M). The S protein, composed of a prominent globular S1 subunit and an S2 subunit anchored in the membrane, has been shown to determine cell tropism and virus-neutralizing epitopes [5] . Point mutations and recombination occur frequently in the S1 gene and result in the existence of many serotypes [3] . The distribution of these serotypes is geographically restricted, and S1 gene variants are unique to different areas [7, 8] . The cross virusneutralization (VN) test can be used to determine IBV serotypes; however, the procedure is time-consuming.
Recently, a molecular genetic technique based on the S1 gene has been reported in a number of countries for IBV classification instead of the cross VN test [6, 8, 18] . In Japan, Mase et al. reported that IBV field strains isolated in Japan could be classified into five S1 genotypes [11, 12] . As mentioned above, S1 gene variants are unique to different areas, and two (JP-I and JP-II) out of five Japanese S1 genotypes are unique to Japan. However, the other three (JP-III, Mass and 4/91) S1 genotypes are also present in other countries, suggesting that the global distribution of chickens and their products may have some influence on IBV genotype distribution [10, 17] .
There have been very few reports on the relationship between genotypes and serotypes of IBV [15, 16] . The S1 gene is a major determinant of IBV serotype; however, the appearance of variants of the S1 gene is not always associated with the appearance of antigenic variants [6] .
When IB outbreaks occur in chicken farms, rapid determination of the virus serotype and rapid selection of an IB vaccine corresponding to the serotype of the field isolate are needed. For the control of IB outbreaks in broiler chicken farms in particular, these processes need to occur even more rapidly because of their short lifetime. In general, a VN test for IBV requires at least one to two weeks to be completed, so it is not appropriate for use in rapid determination of IBV serotypes. Therefore, a more rapid method for determining IBV serotypes is needed. In the present study, we attempted to establish a simple detection method for classification of IBV S1 genotypes by direct reverse transcriptase-polymerase chain reaction (RT-PCR). Then, to evaluate the usefulness of the S1 genotype-specific RT-PCR, we examined the relationship between S1 genotypes and serotypes of IBV in Japan.
MATERIALS AND METHODS

Viruses:
Five vaccine strains (Nerima, TM86, C78, AK01 and 4/91) and 46 IBV field isolates were used for the present study. The IBV field isolates, which were isolated between 1998 and 2008 with specific pathogen-free (SPF) chicken embryonated eggs, were used after four passages in SPF chicken kidney (CK) cell culture.
Partial S1 gene sequencing and determination of S1 genotype-specific primers: Sequencing of the S1 genes of IBV and phylogenetic tree analysis were conducted according to the procedure described by Mase et al. [10] . Viral RNA was extracted using a QIAamp Viral RNA Kit (Qiagen Inc., Valencia, CA, U.S.A.). Amplification of the S1 genes was performed by RT-PCR using a One Step RT-PCR Kit (Qiagen Inc.). Briefly, reverse transcription was performed at 56C for 30 min, early PCR activation was performed at 95C for 5 min and then a cycle including denaturing at 94C for 30 sec, annealing at 50C for 1 min and extension at 72C for 1 min was repeated 30 times, with a subsequent further extension at 72C for 7 min. The RT-PCR oligonucleotide primers conserved in the IBV strains in Japan were S1 cons25 5' GTGACTCTTTTGTGTGCACT and S1 cons696 3' GAGGTTTGTTAGCATGCCAG. The RT-PCR was designed to include the hypervariable region in the DNA fragment of 671 bp (25-696 bp); that is, the primers were designed to select the region starting four bases behind the 3' end of Mase's upper primer and fifty bases behind Mase's lower primer [10] . The RT-PCR products were purified using a QIA Quick PCR Purification Kit (Qiagen Inc.), and sequencing of the S1 genes was outsourced to Griner Japan Inc. (Tokyo, Japan). Agreement and analysis of the S1 gene sequence data were conducted using GENE-TYX ® ver. 8.0 (Genetyx Corporation, Tokyo, Japan), and the phylogenetic tree analysis was conducted by the UPGMA method to classify the S1 genotypes. For the phylogenetic tree analysis, the 4/91 strain (accession No. AF093794) and QX strain (accession No. AF193423) from GenBank were used as references. On the basis of the sequencing data of the S1 genotype samples, we determined each genotype-specific primer set; that is, each upper primer was designed to be located within the S1 hypervariable regions (87-183, 396-447 bp) or at neighboring regions ( Table 1 ). The numbering of primer locations refers to the H120 S1 gene sequence (accession No. M21970 J04329). The specificity of the primer sets was examined by conducting RT-PCR for the S1 genes of the five IBV vaccine strains and the 46 IBV field isolates.
Production of antiserum: Antiserums against the five IBV vaccine strains (shown above) were generated in SPF chickens kept in separate rooms. Each four-week-old chicken was inoculated intratracheally with 10 4 EID 50 of each vaccine strain. Blood was obtained three weeks after inoculation, and the collected serum was heat-inactivated and stored at -20C.
Cross virus-neutralizing (VN) test for vaccine strains:
To determine the serotype of the five IBV vaccine strains, the cross VN test was performed on 10-day-old SPF embryonated eggs. Serial ten-fold dilutions of IBV strains were prepared (10 1 -10 6 EID 50 /0.1 ml), and each dilution was mixed with the same volume of each antiserum and maintained at 4C overnight. Eggs were then inoculated with 0.1 ml of the virus-serum mixtures five eggs each and incubated at 37C. For the virus positive control, the virus-PBS mixtures were inoculated in the same manner as described above. Seven days after inoculation, pathological changes in the embryos were observed, and the EID 50 was determined. The ratio of virus-serum EID 50 to virus-PBS EID 50 was the neutralization index (NI). A homologous NI larger than 2.0 from all heterologous NIs was indicating a independent serotype.
One-direction cross virus-neutralizing test:
To determine the serotype of the field IBV isolates, a one-direction cross VN test with constant serum and diluted virus was employed in CK cell culture. Each anti-IBV serum was diluted to adjust the neutralization index (NI) to 3.0. Serial ten-fold dilutions of IBV field isolates and the five serotype strains were prepared (10 1 -10 4 TCID 50 /50 l), and each dilution was mixed with the same volume of each serotype antiserum and maintained at 4C overnight. The virusserum mixtures were inoculated into four wells of 96 well microplates of CK cell culture and incubated in a 5% CO 2 atmosphere at 37C. Seven days after inoculation, the microplates were observed for the cytopathogenic effect (CPE). The serotype of field isolates showing an NI of 2.0 or higher was considered identical to the serotype used for the anti-IBV serum preparation. Strains for which the NI was in the range of 1.5-2.0 were regarded as displaying a tendency for the serotype. 
RESULTS
Amplification of IBV S1 genes by RT-PCR:
The S1 genes of the five vaccines and 46 IBV field isolates could be amplified satisfactorily by conserved primers. The five vaccines were classified into different genetic clusters by phylogenetic tree analysis (JP-1, JP-II, JP-III, Mass and 4/91) as previously reported. Most of the field isolates were classified into either JP-1, JP-II, JP-III or Mass; however, a few isolates were classified into the 4/91 genotype cluster usually distributed in Western Europe (Fig. 1) .
Amplification of the S1 genes using a type-specific RT-PCR primer set: The S1 genes from the 46 IBV field isolates were specifically amplified using genotype-specific primer sets, and the results were matched to the phylogenetic tree analysis data (Table 2) . However, occasionally, isolates were nonspecifically amplified using the Mass type primer set (Fig. 2) .
Cross virus-neutralizing test for vaccine strains:
The NI of each homologous anti-IBV serum was in the range to 4.0 to 5.8 (Table 3 ). All NIs values from the heterologous VN tests of six vaccine strains in this study were lower than 2.0 versus the homologous NI.
Concordance between S1 sequence-based genotypes and serotypes: The one-direction cross VN test showed that 36 of the 46 IBV field isolates either belonged to or showed a tendency for serotypes and that 30 of these 36 isolates were concordant to the genotypes. The concordance rate including two cases of serotypetendency was 65.2% (Table 4) . The JP-I, JP-II, JP-III and Mass genotypes correlated well with serotypes C78, TM86, AK01 and Massachusetts, respectively. The 4/91 serotype was not detected among the field isolates. However, 10 IBV field isolates (S1 genotypes: JPI, JPII, Mass and 4/91) did not respond to any serotype antiserum, thus showing a discordance between serotype and S1 genotype.
DISCUSSION
The phylogenic analysis in this study showed that IBV vaccine strains and field isolates in Japan could be classified into five genetic groups (JP-I, JP-II, JP-III, Mass and 4/91). The phylogenic analysis data matched those previously reported [11] . One of the groups, genotype 4/91, was a new group that has only been isolated since 2003 in Japan [12] . The sequence homology to the 4/91 strain of one of the field isolates (JP/Miyazaki-2/2003) was 99.0% (716 bp), and that of another (JP/Yamaguchi/2003) was 96.0% (716 bp). Outbreaks of the 4/91(793B) type occurred in 1990s in Western Europe, and outbreaks have occurred sporadically since then in that region [17] . The reason why 4/91 has not remained endemic to Western Europe and has been detected in recent years in Japan is unknown. It is noteworthy that the detection of 4/91 strains in Japan began after marketing of the 4/91 vaccine in this country. Shimazaki [14] reported that one of the 4/91 isolates in Japan might be derived from the vaccine, and others have been closely linked to French and Spanish isolates. In the U.S.A., after the introduction of a new vaccine from the Netherlands, a new IBV variant became endemic, and the S1 gene sequence was highly homologous to that of the vaccine strain [13] .
In this study, we showed IBV genotypes recently isolated in Japan based on the S1 gene sequences determined by genotype-specific RT-PCR. This method is simpler and more rapid than the RFLP described in a previous report. In this study, the upper primers were located in the hypervariable regions (87-183, 396-447 bp) or neighboring positions. This means that the genotype-specific RT-PCR method will be of no use if antigenic shifts occur among the currently existing field IBV strains in Japan. The genotype-specific RT-PCR might be a useful tool for only a limited period in Fig. 1 . Phylogenetic tree of partial S1 gene sequences for IBV field isolates in Japan and reference strains (inbold). TM86w, 4/91, AK01, Nerima and C78 are vaccine strains, and QX is a Chinese strain. Names are in accordance with Cavanagh [1] : country/region or origin/year of isolation.
Japan. Lin et al. [9] reported the classification of the S gene RFLP in Japan; however, the majority of recently arisen field IBV strains in the country cannot be amplified using the primers that they developed (unpublished data), which indicates a genetic change of the S gene during the last 15-20 years in Japan. However, the use of vaccines with the genotypes that are the same as those of field IBV strains, even if a discrepancy is found between the field IBV serotypes and those of the vaccine strains, will contribute to reducing the risk of inducing new IBV variants and increase the length of time during which the genotype-specific RT-PCR can be utilized in Japan. Key points for the control of IBV outbreaks are determination of the serotype of field IBV types that are spreading and use of a vaccine, the serotype of which matches that of the field IBV.
A rapid and convenient genetic technology for determining IBV serotypes to replace the VN test is required. Therefore, we examined the serotypes of Japanese vaccine strains and determined the correlation between serotypes and S1 genotypes by genotype-specific RT-PCR. The serotypes of the five Japanese vaccine strains were different from each other. In addition, the genotypes of the five vaccine strains were also distinguishable as described above. This means there are five distinguished IB live vaccines in Japan, serologically and genetically. Therefore, using the relationship between serotype and S1-based genotype for the five IB vaccine strains as an indicator, we tried to examine the concordance rate between the serotype and the genotype for the field isolates of IBV in Japan. For the Japanese field isolates in this study, the concordance rate, including the serotypetendency cases, between the serotypes and the S1-based genotypes was 65.2%, indicating that the genotype-specific RT-PCR is effective as a simple and rapid method for speculating IBV serotype that can replace the VN test. This rate is not too high but is also not too low, and therefore this method to detect the S1 genotype could be utilized as one of the available tools in the field. Furthermore, use of a vaccine with the same S1 genotype will avoid generation of new variant strains as mentioned above.
Further studies are needed to confirm whether the genotype-specific RT-PCR is directly applicable to IBV-infected materials from farms. Currently, five serotype vaccines are available in Japan. Despite the common use of these vaccines, many classified and unclassified IBV serotypes are isolated, indicating that an inadequate method of vaccination has been achieved in Japan. This may result in recombination between field IBV and vaccine strains. To control IB in the field, it is important to use vaccines of appropriate genotypes and serotypes that can suppress or reduce genetic recombination to a limited range and induce a sufficient antibody level to prevent the appearance of mutants.
The present study indicates that genotype-specific RT-PCR could be a convenient and useful tool for determining IBV serotypes and could contribute to the control of IBV outbreaks in Japan. 
